Evidence map›Paper›PMID 40538975›Full record

ArticleNpj biosensing2024

Towards early diagnosis and screening of Alzheimer's disease using frequency locked whispering gallery mode microtoroids.

Adley Gin, Phuong-Diem Nguyen, Geidy Serrano, Gene E Alexander, Judith Su

Abstract read
In one paragraph

Article in Npj biosensing, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Adley GinWyant College of Optical Sciences, The University of Arizona, Tucson, AZ USA.
Phuong-Diem NguyenDepartment of Biomedical Engineering, The University of Arizona, Tucson, AZ USA.
Geidy SerranoBarrow Neurological Institute, Phoenix, AZ USA.
Gene E AlexanderEvelyn F. McKnight Brain Institute, The University of Arizona, Tucson, AZ USA.
Judith SuWyant College of Optical Sciences, The University of Arizona, Tucson, AZ USA.

Funding

Research Education ComponentP30AG019610 · NIA · SUN HEALTH RESEARCH INSTITUTE · PI REIMAN, ERIC MICHAEL · 2001 to 2020
$32.5M
Research Education ComponentP30AG072980 · NIA · BANNER HEALTH · PI ALIREZA ATRI · 2021 to 2026
$24.9M
National Brain and Tissue Resource for Parkinson's Disease and Related DisordersU24NS072026 · NINDS · BANNER SUN HEALTH RESEARCH INSTITUTE · PI BEACH, THOMAS G · 2011 to 2015
$7.8M
Label-free single molecule detection for basic science and translational medicineR35GM137988 · NIGMS · UNIVERSITY OF ARIZONA · PI SU, JUDITH · 2020 to 2024
$1.8M
Ultra-sensitive and label-free detection of Alzheimer's disease biomarkersR03AG055020 · NIA · UNIVERSITY OF ARIZONA · PI SU, JUDITH · 2017 to 2018
$164k
NIA NIH HHS P30 AG019610NIA NIH HHS P30 AG072980NIA NIH HHS R03 AG055020NIGMS NIH HHS R35 GM137988NINDS NIH HHS U24 NS072026
6 · The paper itself

Abstract

Alzheimer's disease (AD) is a form of dementia marked by amyloid plaques and neurofibrillary tangles in the brain. Amyloid beta (Aβ) is an AD biomarker which is linked to these plaques and tangles. Measuring Aβ levels can help with early AD diagnosis and aid in drug studies and delaying dementia. This is challenging, however, due to low AD biomarker levels in biofluids. Here we use FLOWER (frequency-locked optical whispering evanescent resonator) to quantify levels of post-mortem cerebrospinal fluid (CSF) Aβ42 in control, mild cognitive impairment (MCI), and AD participants. FLOWER measures the resonant wavelength shift of a microtoroid due to changes in the refractive index within its evanescent field. FLOWER can measure CSF Aβ42 (area under curve, AUC = 0.92) with higher performance than ELISA (AUC = 0.82) and can distinguish between control and MCI samples. This demonstrates FLOWER's ability to screen CSF samples for diagnosis of AD.

Indexed as

DiagnosisImaging and sensing

Identifiers

PMID40538975
PMCPMC12173943

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.